Literature DB >> 17142140

Adipose tissue, hepatic, and skeletal muscle insulin sensitivity in extremely obese subjects with acanthosis nigricans.

Dominic N Reeds1, Charles A Stuart, Obed Perez, Samuel Klein.   

Abstract

We evaluated insulin action in skeletal muscle (glucose disposal), liver (glucose production), and adipose tissue (lipolysis) in 5 extremely obese women with acanthosis nigricans (AN), who had normal oral glucose tolerance, and 5 healthy lean subjects, by using a 5-stage pancreatic clamp and stable isotopically labeled tracer infusion. Basal plasma insulin concentration was much greater in obese subjects with AN than lean subjects (54.8 +/- 4.5 vs 8.0 +/- 1.3 microU/mL, P < .001), but basal glucose and free fatty acid concentrations were similar in both groups. During stage 1 of the clamp, glucose rate of appearance (R(a)) (2.6 +/- 0.3 vs 3.7 +/- 0.3 micromol x kg FFM(-1) x min(-1), P = .02) and palmitate R(a) (2.4 +/- 0.6 vs 7.0 +/- 1.5 micromol x kg FFM(-1) x min(-1), P < .05) were greater in obese subjects with AN than lean subjects despite slightly greater plasma insulin concentration in subjects with AN (3.0 +/- 0.7 vs 1.1 +/- 0.4 microU/mL, P < .05). The area under the curve for palmitate R(a) (1867 +/- 501 vs 663 +/- 75 micromol x kg FFM(-1) x 600 min(-1), P = .03) and glucose R(a) (1920 +/- 374 vs 1032 +/- 88 micromol x kg FFM(-1) x 600 min(-1), P = .02) during the entire clamp procedure was greater in subjects with AN than lean subjects. During intermediate insulin conditions (plasma insulin, approximately 35 microU/mL), palmitate R(a) was 5-fold greater in subjects with AN than in lean subjects (2.6 +/- 1.1 vs 0.5 +/- 0.2 micromol x kg FFM(-1) x min(-1), P = .05). Maximal glucose disposal was markedly lower in obese subjects with AN than in lean subjects (13.0 +/- 0.8 vs 23.4 +/- 1.8 mg x kg FFM(-1) x min(-1), P = .01) despite greater peak plasma insulin concentration (1842 +/- 254 vs 598 +/- 38 microU/mL, P < .05). These data demonstrate obese young adults with AN have marked insulin resistance in multiple tissues. However, marked insulin hypersecretion can compensate for impaired insulin action, resulting in normal glucose and fatty acid metabolism during basal conditions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17142140     DOI: 10.1016/j.metabol.2006.08.006

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  13 in total

1.  Muscle hypertrophy in prediabetic men after 16 wk of resistance training.

Authors:  Charles A Stuart; Michelle L Lee; Mark A South; Mary E A Howell; Michael H Stone
Journal:  J Appl Physiol (1985)       Date:  2017-06-29

2.  Cerebrospinal fluid metabolomics implicate bioenergetic adaptation as a neural mechanism regulating shifts in cognitive states of HIV-infected patients.

Authors:  Alex M Dickens; Daniel C Anthony; Reena Deutsch; Michelle M Mielke; Timothy D W Claridge; Igor Grant; Donald Franklin; Debra Rosario; Thomas Marcotte; Scott Letendre; Justin C McArthur; Norman J Haughey
Journal:  AIDS       Date:  2015-03-13       Impact factor: 4.177

3.  Adipose tissue fatty acid metabolism in insulin-resistant men.

Authors:  A S T Bickerton; R Roberts; B A Fielding; H Tornqvist; E E Blaak; A J M Wagenmakers; M Gilbert; S M Humphreys; F Karpe; K N Frayn
Journal:  Diabetologia       Date:  2008-05-27       Impact factor: 10.122

4.  Insulin-stimulated translocation of glucose transporter (GLUT) 12 parallels that of GLUT4 in normal muscle.

Authors:  Charles A Stuart; Mary E A Howell; Yi Zhang; Deling Yin
Journal:  J Clin Endocrinol Metab       Date:  2009-06-23       Impact factor: 5.958

5.  Slow-twitch fiber proportion in skeletal muscle correlates with insulin responsiveness.

Authors:  Charles A Stuart; Melanie P McCurry; Anna Marino; Mark A South; Mary E A Howell; Andrew S Layne; Michael W Ramsey; Michael H Stone
Journal:  J Clin Endocrinol Metab       Date:  2013-03-20       Impact factor: 5.958

6.  Downregulation of adipose tissue fatty acid trafficking in obesity: a driver for ectopic fat deposition?

Authors:  Siobhán E McQuaid; Leanne Hodson; Matthew J Neville; A Louise Dennis; Jane Cheeseman; Sandy M Humphreys; Toralph Ruge; Marjorie Gilbert; Barbara A Fielding; Keith N Frayn; Fredrik Karpe
Journal:  Diabetes       Date:  2010-10-13       Impact factor: 9.461

Review 7.  Fatty acids, obesity, and insulin resistance: time for a reevaluation.

Authors:  Fredrik Karpe; Julian R Dickmann; Keith N Frayn
Journal:  Diabetes       Date:  2011-10       Impact factor: 9.461

8.  One day of overfeeding impairs nocturnal glucose but not fatty acid homeostasis in overweight men.

Authors:  Faidon Magkos; Gordon I Smith; Dominic N Reeds; Adewole Okunade; Bruce W Patterson; Bettina Mittendorfer
Journal:  Obesity (Silver Spring)       Date:  2013-09-10       Impact factor: 5.002

9.  Insulin resistance and muscle insulin receptor substrate-1 serine hyperphosphorylation.

Authors:  Charles A Stuart; Mary E A Howell; Brian M Cartwright; Melanie P McCurry; Michelle L Lee; Michael W Ramsey; Michael H Stone
Journal:  Physiol Rep       Date:  2014-12-03

Review 10.  Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease.

Authors:  Un Ju Jung; Myung-Sook Choi
Journal:  Int J Mol Sci       Date:  2014-04-11       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.